Alzheimer's Disease Research & Clinical Trials

Physician-scientists at Froedtert & the Medical College of Wisconsin are actively involved in searching for new and more effective treatments for Alzheimer’s disease and related memory disorders. The Memory Disorders Program is internationally recognized for research on early risk factors for Alzheimer’s disease and for developing neuro-imaging techniques to detect the disease before symptoms appear. 

Research includes:

  • Studying memory enhancing drugs to prevent and treat Alzheimer’s disease. These studies give patients with mild memory loss or Alzheimer’s disease access to investigational medications that may not yet be available to the public. Trials of new and existing drugs offer hope for stabilizing Alzheimer’s disease or preventing mild memory disorders from worsening. While enrolled in a drug study, the patient receives ongoing medical assessment at no charge.
  • Using functional magnetic resonance imaging (fMRI) to identify people at risk for Alzheimer’s disease. fMRI is a technique that takes detailed pictures of the brain very quickly. It can identify areas of the brain that become active in response to different tasks, and can give detailed pictures of the exact brain location for memory. fMRI is playing a significant role in the early detection of Alzheimer’s disease. 
    • Adult children of people who have been diagnosed with Alzheimer’s disease. These children have a higher risk of developing Alzheimer’s disease in the future.
    • Older adults who have mild memory loss. The patients are tested over five years to help determine if an fMRI scan can be used to predict who will develop Alzheimer’s disease.


For memory disorders:

  • 414-805-3666
Request AppointmentView Treatment Team


Neurosciences Center, Froedtert Hospital 9200 W. Wisconsin Ave.
Milwaukee, WI 53226

All Neurology Locations